Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease

Sponsor
University Hospital, Grenoble
Study ID
NCT06998316
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Screening questionnaire — OTHER
    Every patient will answer the 2 screening questionnaires given to them, once at baseline and a second time after 1 month.

Study Details

The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease. DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease. The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct. Then, the main question is: is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one. Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.

Key Dates

First listed
May 31, 2025
Start date
May 31, 2025
Status verified
May 2025
Primary completion
Apr 30, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
220 participants (estimated)

Arms

  • Arm: People with inflammatory bowel disease
    Patient followed in gastro-enterology for an inflammatory bowel disease. These represent every-patient in our study.

Primary Outcome Measure

translation and cross-cultural adaptation in french of the questionnaires developped by Di Marco et al (2017) and Variola et al (2020) [ Time Frame: 13 months ]

Central Contacts

Find similar trials

Nationwide
Crohn's disease trialsUlcerative colitis trialsGastroenterology trialsInflammatory bowel disease trialsAutoimmune disease trials

Related Studies